Meningitis Vaccine Study
Participants needed: Grade 7 boys and girls
Do you want to protect your child against Meningitis?
About meningococcal disease
- Meningococcal disease is caused by the bacteria Neisseria meningitidis and can result in very severe disease such as sepsis (blood infection) and meningitis.
- Children under two years of age and adolescents/young adults aged 15-20 years have the highest rates of disease.
What is the purpose of this study?
- In Nova Scotia all babies are offered a meningococcal type C vaccine at 12 months and adolescent students are offered a meningococcal vaccine that protects against four types (“quadrivalent”) of the meningococcus bacteria.
- There are three kinds of quadrivalent meningococcal vaccines available in Canada and provided by provinces. All three of these vaccines are more than 90% effective in protecting adolescents against meningococcal disease.
- The three vaccines have not been directly compared against each other in a single study before.
- Researchers at CCfV plan to test if there is any difference between the three vaccines, and if any of them is superior to the other two in protecting youth at this age.
Is my child eligible to participate?
- We are in need of healthy teenage boys and girls who are going into Grade 7 and have not had the quadrivalent meningococcal vaccine yet.
- The study involves three visits to the study clinic over the course of one year.
- These visits will include a physical exam, vaccination, blood tests, and questions about your child’s health.
- The study will take about 3-4 hours of your time in total.
You will receive:
- Parents will receive $25/visit and a parking pass for the IWK Health Centre.
- Children will receive a $25 gift card at each visit as a token of our appreciation for travel and time to take part in the study.
Contact Pamela MacIntyre
Phone (902) 470-8948